Results 1 to 10 of about 39,625 (242)

Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study [PDF]

Intestinal Research, 2023
Background/Aims We conducted a nationwide population-based study to investigate incidence rates of colorectal and biliary cancers according to accompanying primary sclerosing cholangitis in Korean ulcerative colitis patients.
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park   +5 more
doaj   +1 more source

Primary sclerosing cholangitis [PDF]

Canadian Journal of Gastroenterology, 2008
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by inflammation and fibrosis of the bile ducts, resulting in end-stage liver disease and reduced life expectancy. PSC primarily affects young and middle-aged men, often in association with underlying inflammatory bowel disease.
Marina G Silveira, Keith D Lindor
openaire   +5 more sources

Primary sclerosing cholangitis [PDF]

Translational Gastroenterology and Hepatology, 2021
Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease characterized by inflammatory destruction of the intrahepatic and/or extrahepatic bile ducts, leading to bile stasis, fibrosis, and ultimately to cirrhosis, and often requires liver transplantation (LT).
Anahita, Rabiee, Marina G, Silveira
openaire   +2 more sources

Primary sclerosing cholangitis with partial steroid responsiveness: a case report

Fujita Medical Journal, 2023
A 69-year-old woman suspected to have IgG4-related sclerosing cholangitis causing bile duct stenosis was transferred from another hospital after diarrhea, eosinophilia, and eosinophilic infiltration were detected and prednisolone was prescribed ...
Satoshi Yamamoto, Kazuo Inui, Yoshiaki Katano, Hironao Miyoshi, Kenji Notohara   +4 more
doaj   +1 more source

Primary sclerosing cholangitis

Best Practice & Research Clinical Gastroenterology, 2010
Primary sclerosing cholangitis (PSC) is a chronic bile duct disease leading to fibrotic biliary strictures and liver cirrhosis. The patient population is heterogeneous with regard to disease progression and the presence of co-morbidities, complicating the practical handling of patients as well as studies of pathogenetic mechanisms. The aetiology of PSC
Tom H, Karlsen, Erik, Schrumpf, Kirsten Muri, Boberg   +2 more
  +7 more sources

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases [PDF]

, 2020
In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Alpini, Gianfranco, Francis, Heather, Kennedy, Lindsey, Kundu, Debjyoti, Meadows, Vik   +4 more
core   +1 more source

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports

Journal of Medical Case Reports, 2023
Background Overlap syndrome between primary biliary cholangitis and primary sclerosing cholangitis is an extremely rare condition that has been reported in only few published cases so far in the literature.
Haythem Yacoub, Sarra Ben Azouz, Hajer Hassine, Habiba Debbabi, Dhouha Cherif, Feriel Ghayeb, Seif Boukriba, Héla Kchir, Nadia Maamouri   +8 more
doaj   +1 more source

The natural history of primary sclerosing cholangitis in 781 children. A multicenter, international collaboration [PDF]

, 2017
There are limited data on the natural history of primary sclerosing cholangitis (PSC) in children. We aimed to describe the disease characteristics and long-term outcomes of pediatric PSC.
Abdou, Reham, Alqoaer, Khaled, Amin, Mansi, Amir, Achiya Z, Auth, Marcus, Bazerbachi, Fateh, Broderick, Annemarie, Chan, Albert, Cotter, Jillian, Deneau, Mark R, Doan, Sylvia, El-Matary, Wael, El-Youssef, Mounif, Ferrari, Federica, Furuya, Katryn N, Gottrand, Frederic, Gottrand, Madeleine, Gupta, Nitika, Homan, Matjaz, Iorio, Raffaele, Jensen, M K, Kamath, Binita M, Kolho, Kaija-Leena, Konidari, Anastasia, Koot, Bart, Ledder, Oren, Mack, Cara, Martinez, Mercedes, Miloh, Tamir, Mo Kim, Kyung, Mohan, Parvathi, O'Cathain, Niamh, Papadopoulou, Alexandra, Ricciuto, Amanda, Sathya, Pushpa, Saubermann, Lawrence, Shteyer, Eyal, Smolka, Vratislav, Tanaka, Atushi, Valentino, Pamela L, Varier, Raghu, Venkat, Veena, Vitola, Bernadette, Vos, Miriam B, Woynarowski, Marek, Yap, Jason   +45 more
core   +6 more sources

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report

World Journal of Surgical Oncology, 2018
Background Diagnostic work-ups in transplanted immunosuppressed patients are a challenge as non-specific findings may be interpreted as transplant-related complications. If the disease in question is rare and slowly developing like pseudomyxoma peritonei
Ebbe Billmann Thorgersen, Espen Melum, Trine Folseraas, Stein Gunnar Larsen, Pål Dag Line   +4 more
doaj   +1 more source

Sclerosing cholangitis

Current Opinion in Gastroenterology, 1995
Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown etiology. Immunogenetic factors are considered important in its pathogenesis. The genetic susceptibility to primary sclerosing cholangitis is associated, in part, with the HLA HLA-DRB1, DQA1, DQB1 haplotype.
Martins, E, Chapman, R
openaire   +6 more sources